Tag: Antipsychotics
Recovery Rate Six Times Higher For Those Who Stop Antipsychotics Within...
People with "serious mental illness" who stop taking antipsychotics are more likely to recover, even when accounting for baseline severity.
Exploring Psychiatric Drug Withdrawal: A Town Hall Discussion Series
Our new discussion series aims to explore what we do and donāt know about safe withdrawal from antidepressants, antipsychotics, benzodiazepines and stimulants.
A Short History of Tardive Dyskinesia: 65 Years of Drug-Induced Brain...
Psychiatry has long turned a blind eye to the full scope of harm associated with TD. New TD drugs "work" by further impairing brain function.
The Latest “Breakthrough Therapy”: Expensive New Drugs for Tardive Dyskinesia
The increased prescribing of antipsychotics, which frequently cause a brain injury that manifests as tardive dyskinesia, has provided pharmaceutical companies with a lucrative new market opportunity.
Antipsychotic Augmentation Increases Risk of Death
A new study finds that adding an antipsychotic to existing antidepressant treatment is associated with a 45% increased risk of early death.
Very Slow Taper Best for Antipsychotic Discontinuation
An article in JAMA Psychiatry advises very slow tapering for best results when discontinuing antipsychotic drugs.
Deep Sleep “Therapy” in Australia in the 1960s & ’70s: Could...
Psychiatry has a history of continuing to perform harmful, even deadly procedures. But does it still happen? Medication-induced akathisia filled two and a half pages of the DSM-IV. Why was it written out of the DSM 5?
Antipsychotics Associated with Severe COVID-19 and Fatal Outcomes
A new study has found a strong association between antipsychotic drugs and higher rates of severe cases of COVID-19.
For People āAt Risk for Psychosis,ā Antipsychotics Associated with Worse Outcomes
Researchers studied whether antipsychotics could prevent transition to full psychosis and found that the drugs worsened outcomes.
Randomized Controlled Trial Confirms That Antipsychotics Damage the Brain
A new study published in JAMA Psychiatry connects antipsychotics with damage to the brain in multiple areas.
Does Stranger Mean Danger?
Are those diagnosed with āmental illnessā more dangerous than other people? Or have we evolved to sense danger from anything that we believe to be different or "strange"?
Review Documents Severe Withdrawal Effects of Psychiatric Drugs
Researchers find that most psychiatric drugs cause severe withdrawal despite attempt s to gradually decrease the dosage.
Eulogy for Abraham Leighton McNeill
A friend said to me recently, "Oh, he suffered such a lot. Thatās over for him." I know their words were intended to comfort me over my sonās suicide. Our fine, excellent son, Abraham, had committed suicide a month before Christmas 2019. Nevertheless, I bridled inwardly at the suggestion, not wanting to remember Abraham as merely the sum of his sufferingsāhe was so much more than that.
Antipsychotic Trials Show Increasing Placebo Response and Declining Drug Response
A new review of antipsychotic trials conducted over the last 24 years finds that the placebo response rate is steadily increasing, and drug response is decreasing.
Largest Survey of Antipsychotic Experiences Reveals Negative Results
A new survey exploring antipsychotic user experience finds that more than half of the participants report only negative experiences.
Review Explores First-Person Experiences of People Taking Antipsychotics
A new systematic review finds that patients report reduced symptoms but also loss of self and agency while taking antipsychotics.
Mental Health Professionals and Patients Often Disagree on Causes of Symptoms
A new study finds that cliniciansā disregard for mental health patientsā insight into their own condition may be detrimental to treatment.
Pervasive Industry Influence in Healthcare Sector Harms Patients
Experts across the globe point to the harms of drug companiesā influence on research, practice, and education in healthcare noting that it compromises patient care.
Researchers Address Dangers of Polypharmacy and Inappropriate Medication Use
A new special issue brings together articles exploring the harmful effects of simultaneous multiple medication use.
How Race and Class Impact Schizophrenia and Substance-Use Diagnoses
A new article explores how psychiatric diagnoses are differentially applied to people of different racial and class backgrounds.
People Diagnosed with Bipolar Disorder at Increased Risk for Parkinson’s
Increased Parkinson's risk could be related to lithium, antipsychotic, and antiepileptic drug use.
How Do We Test the Effects of Long-Term Exposure to Antipsychotics?
A new attempt to study the neurological effects of long-term exposure to antipsychotics uses healthy volunteers on minimal doses for 15 days.
Review Finds FDA Approval of Digital Antipsychotic Misguided
The approval of the digital antipsychotic may open the door for more pharmaceutical company profits without evidence of benefits to patients.
Discontinuation of Antipsychotics Improves Cognitive Functioning
A study, recently published in Psychological Medicine, examined the cognitive functioning of individuals with schizophrenia who discontinued antipsychotics, and those who maintained their antipsychotic...
Anticholinergic Psychiatric Drugs Linked to a 50% Increase in Dementia
People who take anticholinergic drugs, such as antidepressants and antipsychotics, are at a 50% higher risk of dementia.